Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.07	6.59	7.73	5.44	1.96	1.15
Short-Term Investments	0.03	0.05	0.03	0.03	0.04	0.03
Trading Asset Securities	2.9	2.12	0.03	0.03	0.02	0.02
Cash & Short-Term Investments	11	8.76	7.79	5.49	2.02	1.21
Cash Growth	-20.43%	12.53%	41.69%	171.63%	67.77%	-52.83%
Accounts Receivable	23.11	29.95	31.63	30.81	24.2	19.93
Other Receivables	0.05	-	-	-	0.72	0.86
Receivables	23.16	29.95	31.63	30.81	24.92	20.79
Inventory	9.76	10.41	10.88	14.76	14.44	14.52
Prepaid Expenses	0.6	0.51	0.4	0.73	0.73	0.07
Other Current Assets	4.05	3.1	2.22	3.33	3.2	3.17
Total Current Assets	48.57	52.73	52.91	55.12	45.3	39.76
Property, Plant & Equipment	26.91	27.13	25.48	27.47	27.15	25.41
Long-Term Investments	4.45	4.3	3.22	0.7	1.22	1.48
Other Intangible Assets	1.71	1.55	1.52	3.04	3.53	3.64
Long-Term Deferred Tax Assets	0.4	0.28	0.27	0.2	0.16	0.15
Other Long-Term Assets	0.47	0.32	0.32	0.37	0.36	0.33
Total Assets	84.31	86.32	83.72	86.89	77.71	70.76
Accounts Payable	3.67	3.48	6.56	5.11	4.35	4.62
Accrued Expenses	3.02	2.33	1.32	1.99	1.39	1.2
Short-Term Debt	1.25	0.52	0.65	0.78	1.69	2.46
Current Portion of Long-Term Debt	-	1.13	0.69	0.57	0.6	0.47
Current Portion of Leases	0.39	0.48	0.36	0.55	0.64	0.46
Current Income Taxes Payable	0.35	2.42	2.67	1.66	0.18	0.16
Other Current Liabilities	2.92	1.95	1.46	2.3	2	1.82
Total Current Liabilities	11.59	12.32	13.7	12.97	10.84	11.19
Long-Term Debt	-	-	-	-	0.38	-
Long-Term Leases	0.14	0.33	0.49	0.72	0.55	0.95
Total Liabilities	16.69	17.44	18.49	18.32	16.07	16.03
Common Stock	18	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72	3.72
Retained Earnings	40.33	39.6	34.9	29.89	24.73	22.8
Comprehensive Income & Other	4.6	6.52	7.65	14.87	12.87	7.72
Total Common Equity	66.65	67.84	64.27	66.47	59.32	52.24
Minority Interest	0.96	1.04	0.96	2.1	2.32	2.49
Shareholders' Equity	67.61	68.88	65.23	68.57	61.64	54.73
Total Liabilities & Equity	84.31	86.32	83.72	86.89	77.71	70.76
Total Debt	1.78	2.47	2.18	2.63	3.85	4.33
Net Cash (Debt)	9.22	6.29	5.6	2.86	-1.83	-3.12
Net Cash Growth	-16.91%	12.22%	95.69%	-	-	-
Net Cash Per Share	0.51	0.35	0.31	0.16	-0.10	-0.17
Filing Date Shares Outstanding	18	18	18	18	18	18
Total Common Shares Outstanding	18	18	18	18	18	18
Working Capital	36.98	40.4	39.2	42.16	34.46	28.57
Book Value Per Share	3.70	3.77	3.57	3.69	3.30	2.90
Tangible Book Value	64.94	66.29	62.75	63.43	55.8	48.6
Tangible Book Value Per Share	3.61	3.68	3.49	3.52	3.10	2.70
Land	10.36	-	9.24	8.31	8.13	7.55
Buildings	15.35	-	15.73	16.34	15.87	14.72
Machinery	29.92	-	28.78	31.82	29.69	26.07

Source: S&P Capital IQ. Standard template. Financial Sources.